VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial

Hims & Hers Health Executive Compensation (FY25)

HIMS · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Andrew Dudum
Median of the other named officers
$8,395,840
6 officers, excluding the chief executive
Latest say-on-pay support
=
June 11, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on Hims & Hers Health

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
Data as of November 4, 2026Latest filing (8-K): June 15, 2026
10 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Hims & Hers Health brief$500Get the executive brief
Velarion Intel, one year, every company
346 figures on this page: 341 cited to the filing that reported them, 5 calculated from figures it prints. See the citations

More on Hims & Hers Health

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Andrew Dudum: $24,609,077 → $22,958,907 (6.7% lower)
CEO pay ratio: 309:1 → 272:1 (12.0% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Hims & Hers Health's chief executive and what were they paid?
Andrew Dudum, Chief Executive Officer and Chairman, received $22,958,907 in total compensation for fiscal 2025. Dudum's total was 6.7% lower than the $24,609,077 reported for fiscal 2024.
What was Hims & Hers Health's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 99.3% of votes cast for or against in favor at the meeting held June 11, 2026.
Which companies are in Hims & Hers Health's peer group?
The disclosed peer group names Alteryx, Apollo Medical, Box, Bumble and CarGurus, among others.
What is Hims & Hers Health's chief executive pay ratio?
The company reported a chief executive pay ratio of 272:1 for fiscal 2025, against median employee compensation of $84,402.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Andrew Dudum
Chief Executive Officer and Chairman
◇—◇◇◇—◇◇
Yemi Okupe
Chief Financial Officer
◇—◇◇◇—◇◇
Oluyemi Okupe
Chief Financial Officer
◇—◇◇◇—◇◇
Melissa Baird
Chief Operating Officer
◇—◇◇◇—◇◇
Michael Chi
Chief Marketing Officer
◇—◇◇◇——◇
Soleil Boughton
Chief Legal Officer
◇—◇◇◇—◇◇
Irene Becklund
Former Interim Principal Financial Officer
Departed during or after this year
Served on an interim basis
◇—◇———◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Andrew Dudum
Chief Executive Officer and Chairman
◇—◇◇◇—◇◇
Yemi Okupe
Chief Financial Officer
◇—◇◇◇—◇◇
Melissa Baird
Chief Operating Officer
◇—◇◇◇—◇◇
Mike Chi
Chief Commercial Officer
◇—◇◇◇—◇◇
Soleil Boughton
Chief Legal Officer
◇—◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Andrew Dudum
Chief Executive Officer and Chairman
◇—◇—◇—◇◇
Melissa Baird
Chief Operating Officer
◇—◇—◇—◇◇
Yemi Okupe
Chief Financial Officer
◇—◇—◇—◇◇
Mike Chi
Chief Commercial Officer
◇—◇—◇—◇◇
Soleil Boughton
Chief Legal Officer
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Mohamed Elshenawy
Chief Technology Officer
◇◇◇—◇——◇
Andrew Dudum
Chief Executive Officer and Chairman
◇—◇◇◇—◇◇
Nader Kabbani
Former Chief Operating Officer
Departed during or after this year
◇◇◇———◇◇
Yemi Okupe
Chief Financial Officer
◇—◇—◇—◇◇
Melissa Baird
Former Chief Operating Officer
Departed during or after this year
◇—◇———◇◇
Mike Chi
Chief Operating Officer (previously Chief Commercial Officer)
◇—◇—◇—◇◇
Soleil Boughton
Chief Legal Officer
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Andrew DudumRSU◇——◇——◇
Andrew DudumOPTION◇——◇—◇◇
Melissa BairdRSU◇——◇——◇
Mike ChiRSU◇——◇——◇
Mohamed ElshenawyRSU◇——◇——◇
Mr. ChiRSU◇——◇——◇
Mr. ChiRSU◇——◇——◇
Mr. OkupeRSU◇——◇——◇
Mr. OkupeRSU◇——◇——◇
Nader KabbaniRSU◇——◇——◇
Soleil BoughtonRSU◇——◇——◇
Yemi OkupeRSU◇——◇——◇
Fiscal 2022, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Mohamed ElshenawyRSU◇◇——
Andrew DudumRSU◇◇——
Option◇—◇3/10/35
Option◇—◇2/23/32
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/28/33
Option◇—◇2/23/32
RSU◇◇——
Melissa BairdRSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/23/32
Option◇—◇2/28/33
RSU◇◇——
Nader KabbaniRSU◇◇——
Yemi OkupeRSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/28/33
Option◇—◇2/23/32
Mike ChiPSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
Option◇—◇8/9/32
RSU◇◇——
Option◇—◇2/23/32
Option◇—◇2/28/33
RSU◇◇——
Soleil BoughtonPSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/23/32
Option◇—◇2/28/33
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Soleil Boughton
Chief Legal Officer · Offer letter · dated January 5, 2021
Severance multiple◇
Severance cash amount◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Andrew Dudum
Chief Executive Officer and Chairman · Terms as described in the company’s compensation discussion
Severance multiple◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Melissa Baird
Former Chief Operating Officer · Terms as described in the company’s compensation discussion
Severance multiple◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Mike Chi
Chief Operating Officer · Terms as described in the company’s compensation discussion
Severance multiple◇
Severance cash amount◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Mohamed Elshenawy
Chief Technology Officer · Offer letter
Severance multiple◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Clawback◇
Yemi Okupe
Chief Financial Officer · Terms as described in the company’s compensation discussion
Severance multiple◇
Severance cash amount◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Deb Autor
◇◇———◇◇
David Wells
Lead independent director
◇◇————◇
Christopher Payne
◇◇————◇
Andrea Perez
◇◇————◇
Anja Manuel
◇◇————◇
Christiane Pendarvis
◇◇————◇
Kåre Schultz
◇◇————◇
Patrick Carroll
◇◇————◇
Delos Cosgrove
◇◇————◇
Kofi Amoo-Gottfried and Andrew Dudum served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Lead independent director premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Alteryx AYX
  • Apollo Medical symbol not shown
  • Box BOX
  • Bumble BMBL
  • CarGurus CARG
  • Compensia symbol not shown
  • Coursera COUR
  • DigitalOcean DOCN
  • Duolingo DUOL
  • Elastic N.V. ESTC
  • EngageSmart ESMT
  • Five9 FIVN
  • Jamf Holding JAMF
  • PagerDuty PD
  • Privia Health Group PRVA
  • Rapid7 RPD
  • SentinelOne S
  • Smartsheet SMAR
  • Sprinklr CXM
  • Udemy UDMY
  • Yelp YELP

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 11, 2026=◇◇◇
2024June 12, 2025=◇◇◇
2023June 6, 2024=◇◇◇
2022June 1, 2023=◇◇◇
2021June 2, 2022=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Andrew Dudum (Chief Executive Officer and Chairman), FY2025 total compensation $22,958,907 (base salary $494,792) [exec_comp, SEC accession 0001773751-26-000060, filed 2026-04-28]

See a complete sample report

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Tell me when Hims & Hers Health files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Hims & Hers Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Hims & Hers Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Hims & Hers Health's disclosed peer group is defensible, who names Hims & Hers Health back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
346 figures on this page: 341 cited to the filing that reported them, 5 calculated from figures it prints.
341 cited to the filing
5 calculated from the filing

Documents cited

  1. 0001773751-26-000096
    Proposal 3 : Advisory approval of the Company’s executive compensation: For Against Abstentions Broker Non-Votes
  2. 0001773751-26-000060
    2025 Summary Compensation Table · CEO Pay Ratio · Director Compensation · Exhibit · and 2 more sections
  3. 0001773751-26-000022
    EX-10.10
  4. 0001773751-25-000211
    Proposal 3 : Advisory approval of the Company’s executive compensation: For Against Abstentions Broker Non-Votes
  5. 0001773751-25-000136
    2024 Summary Compensation Table · Compensation Discussion and Analysis
  6. 0001773751-24-000185
  7. 0001773751-24-000110
    2023 Summary Compensation Table
  8. 0001773751-23-000155
  9. 0001140361-23-021276
    2022 Summary Compensation Table
  10. 0001193125-22-170297
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Hims & Hers Health executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/HIMS (accessed 2026).
Short form: data: Velarion

The paid brief for Hims & Hers Health

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
10 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Hims & Hers Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Peers Hims & Hers Health discloses

The companies named in HIMS's own disclosed peer group.

AlteryxBoxBumbleCarGurusCourseraDigitalOceanDuolingoElastic N.V.EngageSmartFive9Jamf HoldingPagerDutyPrivia Health GroupRapid7SentinelOneSmartsheetSprinklrUdemyYelp

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy